Health Sciences Acquisiti... (HSAQ)
NASDAQ: HSAQ
· Real-Time Price · USD
13.31
2.59 (24.16%)
At close: Jan 26, 2023, 9:59 PM
Health Sciences Acquisitions 2 Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.83M | 2.77M | 2.32M | 3.1M | 3.28M | 2.5M | 2.08M | 1.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 223K | 221K | 218K | 207K | 183K | 139K | 98K | 44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 2.61M | 2.55M | 2.11M | 2.89M | 3.09M | 2.36M | 1.98M | 1.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -81.36M | -78.89M | -74.49M | -60.68M | -54.39M | -37.92M | -24.21M | -12.2M | -2.59M | -2.3M | -1.58M | -734.76K | -394.76K | -302.88K | -277.06K | -180.75K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 127.62K | 330.88K | 345.14K | 349.18K | 225.59K | 26.32K | 16K | 11.97K | 7.93K | 3.95K |
Pretax Income | -78.27M | -74.88M | -69.44M | -56.77M | -52.28M | -37.18M | -24.55M | -13.24M | -2.74M | -2.05M | -1.46M | -816.44K | -486.75K | -290.92K | -266.72K | -174.39K |
Net Income | -79.76M | -76.37M | -70.93M | -56.77M | -50.79M | -36.18M | -23.29M | -11.78M | -2.74M | -1.67M | -1.33M | -891.88K | -590.72K | -290.92K | -266.72K | -174.39K |
Selling & General & Admin | 26.05M | 26.25M | 26.34M | 23.8M | 22.54M | 16.83M | 11.3M | 6.92M | 2.96M | 2.29M | 1.57M | 726.71K | 386.7K | 482.7K | 456.88K | 360.56K |
Research & Development | 56.42M | 53.7M | 48.77M | 39.78M | 36.44M | 25.31M | 16.75M | 8.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 82.47M | 79.95M | 75.11M | 63.57M | 58.98M | 42.14M | 28.05M | 15.17M | 2.96M | 2.29M | 1.57M | 726.71K | 386.7K | 482.7K | 456.88K | 360.56K |
Interest Expense | -2.78M | -2.74M | -1.83M | 1.86M | 2.74M | 2.6M | 1.81M | 667.48K | -203.25K | 42.6K | -85.02K | 118.23K | 107.91K | 3.95K | 3.95K | 3.95K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50K | 50K | 50K |
Cost & Expenses | 82.7M | 80.17M | 75.33M | 63.78M | 59.16M | 42.28M | 28.15M | 15.22M | 2.96M | 2.29M | 1.57M | 726.71K | 386.7K | 482.7K | 456.88K | 360.56K |
Income Tax Expense | 1.49M | 1.49M | 1.49M | n/a | -1.49M | -1M | -1.26M | -1.46M | n/a | -383.06K | -127.81K | 75.44K | 103.97K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 38.39M | 38.24B | 36.82B | 37.62B | 35.8B | 35.24B | 34.61B | 27.64B | 16.43M | 13.72M | 20.45M | 20.45M | 20.45M | 20.45M | 20.45M | 20.45M |
Shares Outstanding (Diluted) | 38.39M | 38.24B | 36.82B | 37.62B | 35.8B | 35.24B | 34.61B | 27.64B | 16.43M | 13.72M | 20.45M | 20.45M | 20.45M | 20.45M | 20.45M | 20.45M |
EPS (Basic) | -3.06 | -3.01 | -2.52 | -0.86 | -0.45 | -0.08 | -0.11 | -0.14 | -0.16 | -0.09 | -0.07 | -0.04 | -0.03 | -0.01 | -0.01 | -0.01 |
EPS (Diluted) | -3.06 | -3.01 | -2.52 | -0.86 | -0.45 | -0.08 | -0.11 | -0.14 | -0.16 | -0.09 | -0.07 | -0.04 | -0.03 | -0.01 | -0.01 | -0.01 |
EBITDA | -80.65M | -78.18M | -73.78M | -60.68M | -55.88M | -39.9M | -25.94M | -13.71M | -2.59M | -1.91M | -1.44M | -802.18K | -482.81K | -286.97K | -262.77K | -170.44K |
EBIT | 33.56M | 33.56M | 21.16M | -23.51M | -33.56M | -33.95M | -22.11M | -11.94M | -2.31M | -2.01M | -1.55M | -706.23K | -386.86K | -294.82K | -269K | -172.68K |
Depreciation & Amortization | 1.41M | 1.41M | 1.37M | 82.5K | -1.41M | -1.89M | -1.6M | -1.52M | n/a | 383.06K | 131.85K | -67.42K | -88.05K | 71.05K | 69.42K | 65.43K |